Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 22.21%659.02M | 17.59%757.37M | 39.82%1.22B | 99.19%1.44B | 4.96%539.25M | -22.76%644.07M | -18.90%875.44M | -24.36%724.65M | -47.67%513.76M | -27.90%833.85M |
| Notes receivable and accounts receivable | 7.39%947.6M | 7.21%951.71M | 0.26%657.04M | 23.98%465.43M | 12.02%882.42M | 21.15%887.69M | 21.24%655.31M | 129.47%375.4M | 32.20%787.75M | 81.32%732.74M |
| -Accounts receivable | 7.39%947.6M | 7.21%951.71M | 0.26%657.04M | 23.98%465.43M | 12.02%882.42M | 21.15%887.69M | 21.24%655.31M | 129.47%375.4M | 32.20%787.75M | 81.32%732.74M |
| Other receivables (including interest and dividends) | -15.68%26.29M | -9.20%30.55M | -23.67%27.74M | 44.47%22.41M | 59.66%31.18M | 269.94%33.65M | -14.73%36.34M | -53.12%15.51M | -7.53%19.53M | -6.57%9.1M |
| -Other receivable | ---- | -9.20%30.55M | ---- | ---- | ---- | 269.94%33.65M | ---- | -53.12%15.51M | ---- | -6.57%9.1M |
| Advance payment | -8.52%1.26B | -11.91%1.06B | -27.49%1.49B | -19.68%1.35B | -6.53%1.38B | 29.57%1.21B | -5.14%2.06B | -8.33%1.68B | -0.60%1.47B | -28.09%932.99M |
| Inventories | -11.79%2.47B | -10.78%2.72B | -18.39%3.2B | 25.32%3.13B | 16.20%2.8B | 24.85%3.05B | 21.23%3.92B | 14.78%2.5B | 0.82%2.41B | -32.04%2.44B |
| Receivable financing | -93.10%419.53K | -22.81%22.39M | -52.71%8.97M | 76.25%32.2M | -66.20%6.08M | 8.87%29.01M | 38.73%18.98M | -35.30%18.27M | -0.20%17.98M | -35.69%26.65M |
| Other current assets | -19.79%80.72M | -34.24%90.11M | -38.59%86.54M | -6.46%102.71M | 39.56%100.64M | 133.09%137.03M | 122.75%140.93M | 105.64%109.81M | 46.33%72.11M | -26.05%58.79M |
| Total current assets | -5.11%5.44B | -5.88%5.64B | -13.10%6.69B | 20.77%6.55B | 8.36%5.74B | 18.93%5.99B | 7.87%7.7B | 3.38%5.42B | -4.41%5.29B | -23.49%5.04B |
| Non Current assets | ||||||||||
| Other equity investment | 5.29%54.03M | 5.29%54.03M | 0.00%51.32M | 0.00%51.32M | 0.00%51.32M | 0.00%51.32M | 0.00%51.32M | 0.00%51.32M | 13.24%51.32M | 13.24%51.32M |
| Long-term equity investment | -1.04%5.35M | -8.20%4.98M | -6.09%5.08M | -6.09%5.08M | -58.14%5.41M | -77.16%5.42M | -78.79%5.41M | -85.59%5.41M | -74.84%12.92M | -53.76%23.75M |
| Fixed assets | ---- | 35.87%676.68M | ---- | ---- | ---- | -5.25%498.05M | ---- | -1.50%510.06M | ---- | 135.83%525.62M |
| Constru in process | ---- | 23.29%660.95M | ---- | ---- | ---- | 50.17%536.08M | ---- | 59.66%502.14M | ---- | -35.23%356.97M |
| Productive biological assets | 110.76%887.17K | 579.94%1.03M | 353.99%690.29K | -38.19%425.48K | -38.85%420.93K | -77.91%152.05K | -77.91%152.05K | 0.00%688.41K | 0.00%688.41K | 0.00%688.41K |
| Intangible assets | -2.56%176.04M | -3.61%175.78M | -3.93%177M | -3.55%178.98M | -3.60%180.66M | -3.71%182.36M | -3.59%184.24M | -3.75%185.56M | -14.65%187.41M | -14.76%189.4M |
| Development expenditure | --3.03M | --1.3M | --854.33K | --789.32K | ---- | ---- | ---- | ---- | ---- | ---- |
| Goodwill | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M | 0.00%32.86M |
| Long deferred expense | 41.86%20.8M | -19.34%16.01M | 40.24%20.08M | -9.45%18.07M | -3.78%14.67M | 21.77%19.85M | 4.89%14.32M | 1.91%19.95M | 41.44%15.24M | 70.00%16.3M |
| Deferred tax assets | 7.91%95.43M | 23.94%91.82M | 75.54%80.27M | 7.98%76.11M | 66.37%88.44M | 8.11%74.08M | 3.85%45.73M | 22.81%70.49M | 47.08%53.16M | 71.47%68.52M |
| Usufruct assets | 15.86%81.6M | 65.66%87.41M | 127.07%92.48M | 122.70%98.47M | 153.22%70.43M | 81.54%52.77M | 26.17%40.73M | 28.35%44.22M | -26.17%27.81M | -28.07%29.07M |
| Other non current assets | -92.12%7.69M | -94.40%5.39M | -73.23%23.33M | 0.68%30.06M | 1,091.93%97.58M | -23.79%96.18M | -39.93%87.16M | -78.67%29.86M | -91.66%8.19M | 36.62%126.21M |
| Total non current assets | 11.93%1.83B | 16.73%1.81B | 18.57%1.77B | 16.99%1.7B | 16.30%1.63B | 9.04%1.55B | 8.30%1.5B | 3.83%1.45B | 5.34%1.4B | 8.55%1.42B |
| Total assets | -1.33%7.27B | -1.23%7.45B | -7.95%8.47B | 19.97%8.25B | 10.03%7.37B | 16.75%7.54B | 7.94%9.2B | 3.47%6.87B | -2.52%6.7B | -18.18%6.46B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -1.34%2.35B | 1.27%1.91B | -17.76%1.69B | 252.00%1.88B | 34.82%2.38B | 59.40%1.89B | 5.05%2.06B | 29.94%533.05M | 15.98%1.77B | 0.04%1.19B |
| Notes payable and accounts payable | -22.64%1.46B | -14.47%2.05B | -18.53%2.82B | -9.85%2.55B | 11.81%1.89B | 8.41%2.4B | 17.41%3.46B | 18.89%2.83B | -22.18%1.69B | -23.65%2.21B |
| -Notes payable | -29.00%1.02B | -15.92%1.47B | -14.01%2.32B | -3.78%2.22B | 29.86%1.43B | 11.01%1.74B | 17.11%2.69B | 28.80%2.31B | -26.81%1.1B | -29.41%1.57B |
| -Accounts payable | -2.84%446.44M | -10.60%582.89M | -34.39%502.82M | -36.94%326.05M | -21.97%459.49M | 2.03%652M | 18.48%766.36M | -11.50%517.06M | -11.72%588.88M | -4.49%639.04M |
| Contract liabilities | -15.94%547.42M | -35.09%587.6M | -22.21%992.06M | -3.14%1.01B | -26.60%651.23M | 23.68%905.2M | 7.42%1.28B | -21.51%1.04B | 21.56%887.21M | -43.79%731.91M |
| Salaries payable | 17.20%77.75M | 40.49%78.88M | 269.75%91.8M | -30.67%91.33M | -22.15%66.34M | -31.52%56.15M | -61.02%24.83M | -34.34%131.73M | -55.04%85.22M | -53.30%81.99M |
| Taxs payable | -25.74%42.59M | -19.54%37.81M | -12.01%38.14M | -57.97%30.23M | 42.74%57.35M | 22.83%47M | -23.21%43.35M | 29.12%71.92M | -15.43%40.18M | -25.45%38.26M |
| Other payable (including interest and dividends) | 59.92%25.02M | 39.62%23.48M | -13.89%16.9M | -20.63%10.82M | -54.26%15.65M | -4.52%16.82M | 22.84%19.62M | 14.13%13.63M | 66.85%34.21M | -70.25%17.61M |
| -Dividend payable | 84.43%3.16M | 1.94%2.4M | 0.00%1.71M | 0.00%1.71M | 0.00%1.71M | -8.83%2.36M | 171.57%1.71M | 171.57%1.71M | 171.57%1.71M | -93.43%2.59M |
| -Other payable | ---- | 45.76%21.08M | ---- | ---- | ---- | -3.77%14.46M | ---- | 5.36%11.92M | ---- | -24.33%15.03M |
| Non current liabilities due within one year | -5.27%21.98M | 5.10%21.54M | 20.40%23.35M | 58.04%25.59M | 65.06%23.21M | 75.16%20.5M | 42.26%19.39M | 31.42%16.19M | -5.54%14.06M | -15.38%11.7M |
| Other current liabilities | -29.15%59.12M | -44.61%46.97M | -28.72%107.25M | -6.18%86.07M | -6.16%83.45M | 27.14%84.81M | 3.47%150.46M | -23.40%91.74M | 9.66%88.93M | -43.63%66.7M |
| Total current liabilities | -11.27%4.59B | -12.13%4.76B | -18.01%5.78B | 20.12%5.68B | 12.21%5.17B | 24.69%5.42B | 10.37%7.05B | 4.67%4.73B | -3.59%4.61B | -25.10%4.35B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | --3.12M | --3.12M | --3.12M | ---- | ---- | ---- | ---- | ---- |
| Long term account payable | ---- | 30.20%776M | ---- | ---- | ---- | 0.00%596M | ---- | 0.00%596M | ---- | 0.00%596M |
| Deferred tax liabilities | -19.16%490.51K | 46.52%889.05K | 4.91%490.51K | 4.91%490.51K | -93.29%606.78K | -92.09%606.78K | --467.56K | -94.83%467.56K | 1,577.31%9.05M | 1,322.19%7.67M |
| Long term deferred income | 253.72%172.18M | 206.75%175.9M | 247.75%173.29M | 119.22%123.72M | -1.72%48.68M | -4.35%57.34M | 450.76%49.83M | 2.65%56.43M | 6.11%49.53M | 11.73%59.95M |
| Lease liabilities | -30.02%35.4M | 14.75%39.03M | 41.44%41.25M | 45.34%46.3M | 140.36%50.58M | 46.23%34.02M | 15.76%29.16M | 15.27%31.86M | -28.51%21.05M | -24.67%23.26M |
| Total non current liabilities | 27.61%994.07M | 44.17%991.83M | 41.26%954.15M | 24.08%849.63M | 15.30%778.99M | 0.16%687.97M | -0.33%675.46M | -0.42%684.76M | 0.44%675.62M | 0.85%686.88M |
| Total liabilities | -6.18%5.58B | -5.78%5.75B | -12.83%6.73B | 20.62%6.53B | 12.61%5.95B | 21.34%6.11B | 9.34%7.73B | 4.00%5.41B | -3.09%5.28B | -22.38%5.03B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M | 0.00%347.59M |
| Capital reserve funds | -0.94%318.58M | -0.94%318.58M | 0.54%323.08M | 0.54%323.08M | -0.03%321.6M | 0.09%321.6M | -0.11%321.36M | -0.11%321.36M | 0.22%321.71M | 0.10%321.32M |
| Surplus reserve funds | 10.22%110.02M | 10.22%110.02M | 10.22%110.02M | 10.22%110.02M | 30.30%99.81M | 30.30%99.81M | 30.30%99.81M | 30.30%99.81M | 21.06%76.6M | 21.06%76.6M |
| Retained profit | -1.11%421.84M | -5.45%409.61M | -4.78%443.78M | -6.46%429.52M | -3.40%426.57M | -0.71%433.22M | 8.75%466.07M | 10.12%459.19M | 6.70%441.61M | 7.37%436.32M |
| Other composite income | -81.50%589.39K | -167.95%-555.21K | -10.50%631.38K | -20.07%651.25K | 348.75%3.19M | -1.07%817.05K | 4.67%705.45K | 1.33%814.8K | 125.24%709.86K | 128.76%825.88K |
| Shareholders equity without minority interests | -0.01%1.2B | -1.48%1.19B | -0.84%1.23B | -1.46%1.21B | 0.89%1.2B | 1.72%1.2B | 5.14%1.24B | 5.59%1.23B | 3.96%1.19B | 4.17%1.18B |
| Minority interests | 123.32%489.21M | 120.00%509.66M | 114.27%507.78M | 117.25%508.84M | -2.34%219.06M | -5.06%231.66M | -15.61%236.98M | -15.30%234.22M | -18.14%224.31M | -11.43%244M |
| Total shareholder equity | 19.04%1.69B | 18.14%1.69B | 17.68%1.73B | 17.55%1.72B | 0.37%1.42B | 0.56%1.43B | 1.14%1.47B | 1.58%1.46B | -0.31%1.41B | 1.12%1.43B |
| Total liabilityies and equity | -1.33%7.27B | -1.23%7.45B | -7.95%8.47B | 19.97%8.25B | 10.03%7.37B | 16.75%7.54B | 7.94%9.2B | 3.47%6.87B | -2.52%6.7B | -18.18%6.46B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.